Skip to main content
ARXS
NASDAQ Manufacturing

Arxis 10-Q Details Q3 Earnings: $564M Revenue, $83.7M Net Income, New Litigation Accruals

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$49.54
Mkt Cap
$23.315B
52W Low
$33.15
52W High
$61.5
52W Position info
49% above low
Off High info
19% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ARXS sits 49% above its 52-week low of $33.15.

Summary

Arxis filed its Q3 10-Q confirming $564M revenue (+36%) and $83.7M net income, with full financials and newly detailed litigation accruals — a $21.0M Jacksonville guarantee reserve and a $22.0M K-Max verdict under appeal.


Key Events · Earnings and Guidance · ARXS

  • Q3 Revenue Up 36% to $564M

    Revenue of $563.98M versus $414.83M a year ago, with organic growth of 28.7% and $30.1M from acquisitions.

  • Margins Expand, Net Income $83.7M

    Gross margin rose to 54.3% from 49.2%; adjusted EBITDA was $255.9M, or 45.4% of revenue, versus $153.5M (37.0%) a year ago.

  • Jacksonville Guarantee Accrual Raised

    Customer alleges $48.3M of damages on the divested Jacksonville Business contract; Arxis has accrued $21.0M, including $12.0M of incremental expense in Q3.

  • K-Max Verdict Under Appeal

    A jury awarded $22.0M to the plaintiff on loss-of-property and business-interruption claims; the company and its insurers have appealed, with $17.4M accrued and a $7.8M insurance receivable recognized.


Analysis · ARXS · Manufacturing

The headline Q3 numbers were already released via 8-K on October 28, so the market has priced them. What this 10-Q adds is the full audited-style detail: 54.3% gross margin, $255.9M adjusted EBITDA, $493.7M of cash against $1.73B of debt, and two litigation items that were not in the press release — a $21.0M accrual (including $12.0M of new Q3 expense) on the Jacksonville guarantee where the customer claims $48.3M, and a $22.0M jury verdict in the K-Max case now under appeal. Those contingencies, plus the September 2 Schatz acquisition for $140.3M cash, are the genuinely new information for anyone modeling the balance sheet.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARXS was trading at $49.54 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $23.3B. The 52-week trading range was $33.15 to $61.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARXS - Latest Insights

ARXS
Oct 28, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $52.99
Real-time Price: $54.37 info
Change: +$1.38 (+3%) info
Market Cap: $23.418B info
ARXS
Sep 03, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $51.16
Real-time Price: $54.37 info
Change: +$3.21 (+6%) info
Market Cap: $23.418B info
ARXS
Aug 18, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $57.04
Real-time Price: $54.37 info
Change: -$2.67 (-5%) info
Market Cap: $23.418B info
ARXS
Jul 30, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $45.93
Real-time Price: $54.37 info
Change: +$8.44 (+18%) info
Market Cap: $23.418B info
ARXS
Jul 29, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $44.45
Real-time Price: $54.37 info
Change: +$9.92 (+22%) info
Market Cap: $23.418B info